小細胞肺癌:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Small-Cell Lung Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Small-Cell Lung Cancer 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Small-Cell Lung Cancer 38
Nov 05, 2013: ImmunoGen Announces Discontinuation of IMGN901 Study in Small-Cell Lung Cancer 38
Oct 24, 2013: Cornerstone Pharmaceuticals Announces Initiation of Phase II Clinical Trial of CPI-613 for the Treatment of Small Cell Lung Cancer 38
Oct 24, 2013: Nektar and Roswell Park Cancer Institute Announce Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol as a Second-Line Treatment in Patients with Relapsed or Refractory Small Cell Lung Cancer 39
Oct 21, 2013: New Nanopharmaceutical May Help Overcome Resistance to Certain Anticancer Drugs 39
Jun 11, 2013: Critical Outcome Technologies Announces Positive Preclinical Results Of Cancer Drug Candidiate COTI-2 Against p53 Gene Mutations 40
Clinical Trial Profiles 42
Clinical Trial Overview of Top Companies 42
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Novartis AG 46
Clinical Trial Overview of Novartis AG 46
Bristol-Myers Squibb Company 47
Clinical Trial Overview of Bristol-Myers Squibb Company 47
Celgene Corporation 48
Clinical Trial Overview of Celgene Corporation 48
Sanofi 49
Clinical Trial Overview of Sanofi 49
Bayer AG 50
Clinical Trial Overview of Bayer AG 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Amgen Inc. 52
Clinical Trial Overview of Amgen Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
European Organization for Research and Treatment of Cancer 63
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 63
The University of Texas M. D. Anderson Cancer Center 65
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 65
Sarah Cannon Research Institute 66
Clinical Trial Overview of Sarah Cannon Research Institute 66
NCIC Clinical Trials Group 67
Clinical Trial Overview of NCIC Clinical Trials Group 67
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
Radiation Therapy Oncology Group 69
Clinical Trial Overview of Radiation Therapy Oncology Group 69
Southeastern Medical Oncology Center 70
Clinical Trial Overview of Southeastern Medical Oncology Center 70
Japan Clinical Oncology Group 71
Clinical Trial Overview of Japan Clinical Oncology Group 71
Five Key Clinical Profiles 72
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 164


【レポート販売概要】

■ タイトル:小細胞肺癌:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月24日
■ 調査会社:GlobalData
■ 商品コード:GDHC2102CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。